Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) are novel therapeutic agents used for various types of cancer. ICIs have revolutionized cancer treatment and improved clinical outcomes among cancer patients. However, immune-related adverse effects of ICI therapy are common. Cardiovascular immune-rela...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Cardiol
Autors principals: Nso, Nso, Antwi-Amoabeng, Daniel, Beutler, Bryce D, Ulanja, Mark B, Ghuman, Jasmine, Hanfy, Ahmed, Nimo-Boampong, Joyce, Atanga, Sirri, Doshi, Rajkumar, Enoru, Sostanie, Gullapalli, Nageshwara
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2020
Matèries:
Meta-Analysis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7701899/
https://ncbi.nlm.nih.gov/pubmed/33312443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4330/wjc.v12.i11.584
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars